---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-106117"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:39:37.967864+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Longeveron Q3 net loss $17.3M; cash runs late Q1 2026; BLA for HLHS delayed to 2027

## Summary
- Net loss increased 45% to $17.3M for nine months ended Sept 30, 2025 vs $11.9M in prior year.
- Revenue fell 53% to $0.8M; cash and equivalents $9.2M, funding expected only into late Q1 2026.
- Top-line results from pivotal HLHS Phase 2b trial ELPIS II expected Q3 2026, but BLA submission now anticipated in 2027.
- Completed public offering in Aug 2025 raising ~$5.0M; ATM facility of up to $10.7M available.
- Leadership: Than Powell appointed Interim CEO; Dr. Joshua Hare named Executive Chairman; Dr. George Paletta elected to board.

## SEC filing metadata
- accession: 0001213900-25-106117
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390025106117/0001213900-25-106117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390025106117/ea0263460-8k_longever.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-106117
- JSON: https://secwatch.observer/filing/0001213900-25-106117.json
- Plain text: https://secwatch.observer/filing/0001213900-25-106117.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.